Halaven & Neutropenia

23.6%

of users reported Neutropenia

48.8%

also reported Hospitalization

92.4%

are women

Hospitalization

48.8%

Severe reaction

38.6%

Death

9.2%

Life-threatening condition

2.5%

Disability

1.0%

Halaven: general information

30 - 39 years

4.8%

40 - 49 years

16.4%

50 - 59 years

32.1%

60 - 69 years

27.1%

70 - 79 years

17.9%

80 - 89 years

1.7%